Mind-Altering Medicine


The future use of psychedelics as treatment for psychological disorders is once again a possibility, as research on the topic resumes after nearly 40 years of prohibition.

At the University of Arizona, researchers tested psilocybin on a group of volunteers suffering from debilitating cases of obsessive-compulsive disorder (OCD). Of the nine who received the treatment, all reported that symptoms dissolved for a period of at least 24 hours.

Thanks to the persistent efforts and hefty monetary contributions of organizations such as MAPS (Multi-Disciplinary Association for Psychedelic Studies), these studies may open the door to additional research into other possible benefits of psychedelics, and help to garner support of mainstream members of the psychiatric community.